On The Forefront – What You Need To Deliver Biomarker Data
Source: LabConnect
Systems established for traditional pharmacokinetic (PK) and pharmacodynamic (PD) analyses were not designed to support complex clinical trials of new drugs in development. The incorporation of biomarkers into early drug trials has challenged leading companies to reprioritize innovation and drive quality sample management systems. As clinical development pipelines expand, companies should explore partnerships that will allow for scalability, enabling efficient and improved sample management.
Webinar Agenda
Highlighting the importance of quality sample management in the development of immunotherapies
- Bridging the gap between research and clinical operations teams to design custom sample management processes
- Emphasizing the significance of real-time sample tracking to deliver high quality data
- Exploring new innovations and partnerships to enable efficient and improved sample management
- Reducing development timelines to bring effective immunotherapy to patients
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
LabConnect
This website uses cookies to ensure you get the best experience on our website. Learn more